Cancer Research Annual Meeting 2010 2010 Workshops
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, A.
Right arrow Articles by Ray, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, A.
Right arrow Articles by Ray, D. W.
[Cancer Research 63, 812-816, February 15, 2003]
© 2003 American Association for Cancer Research

Endocrinology

Haplotype Analysis of the Polymorphic Human Vascular Endothelial Growth Factor Gene Promoter1

Adam Stevens, Joanne Soden, Paul E. Brenchley, Shirley Ralph and David W. Ray2

Endocrine Sciences Research Group [A. S., J. S., D. W. R.] and Department of Medicine [P. E. B., S. R.], Stopford Building, University of Manchester, Manchester M13 9PT, United Kingdom

The human vascular endothelial growth factor (VEGF) gene is unusually polymorphic,and there is evidence for inheritance of conserved haplotypes.One haplotype, carrying polymorphisms at -460/+405, is associated with enhanced production of VEGF in vitro. The VEGF promoter is activated by phorbol esters and, in endometrial cells, by estrogen. We have analyzed the impact of the common -460/+405 polymorphism on both basal and stimulated VEGF transcription using the human breast cancer cell line MCF7. Because the VEGF promoter is so highly polymorphic, haplotypes were established and analyzed. Carriage of the -460/+405 polymorphisms increased basal promoter activity by 71% compared with the wild-type sequence. However, this effect was dependent on colinearity with a series of further 5' sequence polymorphisms. The -460/+405 polymorphism also increased the mean induction by phorbol ester from 5-fold to 8.5-fold. In contrast to earlier studies in endometrial cells, none of the human VEGF promoter constructs was regulated by estrogen. Overexpression of the estrogen receptor did not confer estrogen regulation to VEGF, implying cell type-specific hormonal regulation. Therefore, carriage of the -460/+405 polymorphism significantly alters VEGF promoter activity and responsiveness. This has implications for the inherited susceptibility of common diseases.




This article has been cited by other articles:


Home page
 Ann OncolHome page
D. H. Kim, W. Xu, S. Kamel-Reid, X. Liu, C. W. Jung, S. Kim, and J. H. Lipton
Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy
Ann. Onc., October 29, 2009; (2009) mdp452v1.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. Hussein, E. Askar, M. Elsaeid, and F. Schaefer
Functional polymorphisms in transforming growth factor-beta-1 (TGF{beta}-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection
Nephrol. Dial. Transplant., October 26, 2009; (2009) gfp532v1.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Q. Liu, Y. Li, J. Zhao, D.-L. Sun, Y.-N. Duan, N. Wang, R.-M. Zhou, and S. Kang
Association of polymorphisms -1154G/A and -2578C/A in the vascular endothelial growth factor gene with decreased risk of endometriosis in Chinese women
Hum. Reprod., October 1, 2009; 24(10): 2660 - 2666.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. Zarbock, D. Hendig, C. Szliska, K. Kleesiek, and C. Gotting
Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum
Hum. Mol. Genet., September 1, 2009; 18(17): 3344 - 3351.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. P. Schneider, M. Radovich, and K. D. Miller
The Role of Vascular Endothelial Growth Factor Genetic Variability in Cancer
Clin. Cancer Res., September 1, 2009; 15(17): 5297 - 5302.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. A. Bradbury, R. Zhai, C. Ma, W. Xu, J. Hopkins, M. J. Kulke, K. Asomaning, Z. Wang, L. Su, R. S. Heist, et al.
Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis
Clin. Cancer Res., July 15, 2009; 15(14): 4680 - 4685.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Zhai, G. Liu, K. Asomaning, L. Su, M. H. Kulke, R. S. Heist, N. S. Nishioka, T. J. Lynch, J. C. Wain, X. Lin, et al.
Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk
Carcinogenesis, December 1, 2008; 29(12): 2330 - 2334.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. P. Schneider, M. Wang, M. Radovich, G. W. Sledge, S. Badve, A. Thor, D. A. Flockhart, B. Hancock, N. Davidson, J. Gralow, et al.
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
J. Clin. Oncol., October 1, 2008; 26(28): 4672 - 4678.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. J. Churchill, J. G. Carter, C. Ramsden, S. J. Turner, A. Yeung, P. E. C. Brenchley, and D. W. Ray
VEGF Polymorphisms Are Associated with Severity of Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3611 - 3616.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Patel, S. Ailawadhi, F. Hernandez-Ilizaliturri, and G. E. Wilding
Vascular Endothelial Growth Factor Polymorphisms in Early-Stage Non-Small-Cell Lung Cancer
J. Clin. Oncol., July 1, 2008; 26(19): 3289 - 3290.
[Full Text] [PDF]

Home page
 JCOHome page
R. S. Heist, R. Zhai, G. Liu, W. Zhou, X. Lin, L. Su, K. Asomaning, T. J. Lynch, J. C. Wain, and D. C. Christiani
VEGF Polymorphisms and Survival in Early-Stage Non-Small-Cell Lung Cancer
J. Clin. Oncol., February 20, 2008; 26(6): 856 - 862.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. Zhai, G. Liu, W. Zhou, L. Su, R. S. Heist, T. J. Lynch, J. C. Wain, K. Asomaning, X. Lin, and D. C. Christiani
Vascular Endothelial Growth Factor Genotypes, Haplotypes, Gender, and the Risk of Non-Small Cell Lung Cancer
Clin. Cancer Res., January 15, 2008; 14(2): 612 - 617.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. G. Kim, Y. S. Chae, S. K. Sohn, Y. Y. Cho, J. H. Moon, J. Y. Park, S. W. Jeon, I. T. Lee, G. S. Choi, and S.-H. Jun
Vascular Endothelial Growth Factor Gene Polymorphisms Associated with Prognosis for Patients with Colorectal Cancer
Clin. Cancer Res., January 1, 2008; 14(1): 62 - 66.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
A. Y. Debrah, S. Mand, M. R. Toliat, Y. Marfo-Debrekyei, L. Batsa, P. Nurnberg, B. Lawson, O. Adjei, A. Hoerauf, and K. Pfarr
Plasma Vascular Endothelial Growth Factor-A (VEGF-A) and VEGF-A Gene Polymorphism are Associated with Hydrocele Development in Lymphatic Filariasis
Am J Trop Med Hyg, October 1, 2007; 77(4): 601 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
G. Kitsios and E. Zintzaras
Genetic Variation associated with Ischemic Heart Failure: A HuGE Review and Meta-Analysis
Am. J. Epidemiol., September 15, 2007; 166(6): 619 - 633.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Zhai, M N Gong, W Zhou, T B Thompson, P Kraft, L Su, and D C Christiani
Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS
Thorax, August 1, 2007; 62(8): 718 - 722.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
D. Chalothorn, J. A. Clayton, H. Zhang, D. Pomp, and J. E. Faber
Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains
Physiol Genomics, July 18, 2007; 30(2): 179 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. Kim, S. Sohn, Y. Chae, Y. Cho, H-I Bae, G Yan, J. Park, M-H Lee, H. Chung, and W Yu
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer
Ann. Onc., June 1, 2007; 18(6): 1030 - 1036.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Buraczynska, P. Ksiazek, I. Baranowicz-Gaszczyk, and L. Jozwiak
Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 827 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. J. Churchill, J. G. Carter, H. C. Lovell, C. Ramsden, S. J. Turner, A. Yeung, J. Escardo, and D. Atan
VEGF polymorphisms are associated with neovascular age-related macular degeneration
Hum. Mol. Genet., October 1, 2006; 15(19): 2955 - 2961.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
S M Hyder
Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 667 - 687.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
H. Garside, C. Waters, A. Berry, L. Rice, H. C Ardley, A. White, P. A Robinson, and D. Ray
UbcH7 interacts with the glucocorticoid receptor and mediates receptor autoregulation.
J. Endocrinol., September 1, 2006; 190(3): 621 - 629.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
T. Higashi, S. Kyo, M. Inoue, H. Tanii, and K. Saijoh
Novel Functional Single Nucleotide Polymorphisms in the Latent Transforming Growth Factor-{beta} Binding Protein-1L Promoter: Effect on Latent Transforming Growth Factor-{beta} Binding Protein-1L Expression Level and Possible Prognostic Significance in Ovarian Cancer
J. Mol. Diagn., July 1, 2006; 8(3): 342 - 350.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Kataoka, Q. Cai, W. Wen, X.-O. Shu, F. Jin, Y.-T. Gao, and W. Zheng
Population-Based Case-Control Study of VEGF Gene Polymorphisms and Breast Cancer Risk among Chinese Women.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1148 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Prior, J. M. Hagberg, C. M. Paton, L. W. Douglass, M. D. Brown, J. C. McLenithan, and S. M. Roth
DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1848 - H1855.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
D. S. Faffe, L. Flynt, K. Bourgeois, R. A. Panettieri Jr., and S. A. Shore
Interleukin-13 and Interleukin-4 Induce Vascular Endothelial Growth Factor Release from Airway Smooth Muscle Cells: Role of Vascular Endothelial Growth Factor Genotype
Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 213 - 218.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. M. Summers, B. M. Coupes, M. F. Brennan, S. A. Ralph, C. D. Short, and P. E. C. Brenchley
VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5
Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2427 - 2432.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. H. Kim, Y. M. Choi, S. H. Choung, J. K. Jun, J. G. Kim, and S. Y. Moon
Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis
Hum. Reprod., October 1, 2005; 20(10): 2904 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. S. Seo, S.-S. Lee, S. I. Kim, W. H. Ryu, K. H. Sa, S. U. Kim, S. W. Han, E. J. Nam, J. Y. Park, W. K. Lee, et al.
Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis
Rheumatology, October 1, 2005; 44(10): 1299 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Bhanoori, K. Arvind Babu, N.G. Pavankumar Reddy, K. Lakshmi Rao, K. Zondervan, M. Deenadayal, S. Kennedy, and S. Shivaji
The vascular endothelial growth factor (VEGF) +405G>C 5'-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study
Hum. Reprod., July 1, 2005; 20(7): 1844 - 1849.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Lu, X.-O. Shu, Y. Cui, N. Kataoka, W. Wen, Q. Cai, Z.-X. Ruan, Y.-T. Gao, and W. Zheng
Association of Genetic Polymorphisms in the VEGF Gene with Breast Cancer Survival
Cancer Res., June 15, 2005; 65(12): 5015 - 5019.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
W M Howell, S Ali, M J Rose-Zerilli, and S Ye
VEGF polymorphisms and severity of atherosclerosis
J. Med. Genet., June 1, 2005; 42(6): 485 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, R. Klaes, R. Henriksson, B. Chen, J. Pamula, W. Pekala, et al.
Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis
Clin. Cancer Res., May 15, 2005; 11(10): 3647 - 3653.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. J. Lee, S. Y. Lee, H.-S. Jeon, S. H. Park, J. S. Jang, G. Y. Lee, J. W. Son, C. H. Kim, W. K. Lee, S. Kam, et al.
Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 571 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Liu, F. Innocenti, M. H. Wu, A. A. Desai, M. E. Dolan, E. H. Cook Jr., and M. J. Ratain
A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter
Cancer Res., January 1, 2005; 65(1): 46 - 53.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
C E Waters, A Stevens, A White, and D W Ray
Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line
J. Endocrinol., November 1, 2004; 183(2): 375 - 383.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
R. W. I. Cooke, J. A. Drury, R. Mountford, and D. Clark
Genetic Polymorphisms and Retinopathy of Prematurity
Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1712 - 1715.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Wu, J. Richer, K. B. Horwitz, and S. M. Hyder
Progestin-Dependent Induction of Vascular Endothelial Growth Factor in Human Breast Cancer Cells: Preferential Regulation by Progesterone Receptor B
Cancer Res., March 15, 2004; 64(6): 2238 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Ray, M. Mishra, S. Ralph, I. Read, R. Davies, and P. Brenchley
Association of the VEGF Gene With Proliferative Diabetic Retinopathy But Not Proteinuria in Diabetes
Diabetes, March 1, 2004; 53(3): 861 - 864.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.